OTCMKTS:MAQAF Atlas Arteria (MAQAF) Stock Price, News & Analysis $3.09 0.00 (0.00%) (As of 09/27/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesShort Interest Get Atlas Arteria alerts: Email Address About Atlas Arteria Stock (OTCMKTS:MAQAF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Atlas Arteria alerts:Sign Up Key Stats Today's Range$3.09▼$3.0950-Day Range$3.06▼$3.7052-Week Range$3.06▼$4.14VolumeN/AAverage Volume3,477 shsMarket CapitalizationN/AP/E RatioN/ADividend Yield2.69%Price TargetN/AConsensus RatingN/A Company OverviewAtlas Arteria Limited owns, develops, and operates toll roads. It holds a 31.14% of interest in the APRR and A79 and 31.17% interest in the ADELAC located in France; 100% interest in the Warnow Tunnel located in Rostock, Germany; 66.67% interest in the Chicago Skyway situated in Chicago and 100% interest in the Dulles Greenway located in Virginia, United States. The company was formerly known as Macquarie Atlas Roads Limited and changed its name to Atlas Arteria Limited in May 2018. Atlas Arteria Limited was incorporated in 2009 and is based in Melbourne, Australia.Read More… Massive NVIDIA Sell-Off: Are We Headed for a Market Collapse? (Ad)You may have heard about NVIDIA's CEO dumping shares of his own company. He sold 4.4 million shares this year. But here's what's even more concerning...Click here for his urgent warning - and 4 steps you need to take today to protect your retirement to Receive MAQAF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Atlas Arteria and its competitors with MarketBeat's FREE daily newsletter. Email Address MAQAF Stock News HeadlinesAtlas Arteria (MAQAF) Receives a Buy from JefferiesSeptember 2, 2024 | markets.businessinsider.comRBC Capital Remains a Hold on Atlas Arteria (MAQAF)August 30, 2024 | markets.businessinsider.comCongress passes legislation in favor of Musk-backed technology Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adoption of this technology for decades. By doing so he has put himself in the crosshairs of an ideological war with the global elites. And yet, while this new technology threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.September 29, 2024 | Porter & Company (Ad)Morgan Stanley Reaffirms Their Hold Rating on Atlas Arteria (MAQAF)July 22, 2024 | markets.businessinsider.comIFM’s stake in Atlas Arteria creeps up to 26pc; Jarden on tradeMay 14, 2024 | afr.comAtlas Arteria’s ‘back-up plan’ to fight French taxesMay 8, 2024 | afr.comAtlas Arteria Ltd's Dividend AnalysisMarch 25, 2024 | finance.yahoo.comAtlas Arteria Full Year 2023 Earnings: EPS: AU$0.22 (vs AU$0.25 in FY 2022)February 29, 2024 | finance.yahoo.comSee More Headlines MAQAF Stock Analysis - Frequently Asked Questions How have MAQAF shares performed this year? Atlas Arteria's stock was trading at $3.95 at the start of the year. Since then, MAQAF shares have decreased by 21.8% and is now trading at $3.09. View the best growth stocks for 2024 here. How do I buy shares of Atlas Arteria? Shares of MAQAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorIndustrials Industry Infrastructure Operations Sub-IndustryN/A Current SymbolOTCMKTS:MAQAF CUSIPN/A CIKN/A Webwww.atlasarteria.com Phone611800621694FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report This page (OTCMKTS:MAQAF) was last updated on 9/29/2024 by MarketBeat.com Staff From Our PartnersThe Bible Says it Clear As DayIt came to me clear-as-day thanks to the Bible… in the Parable of Talents, in the book of Matthew… This pa...Prosperity Research | SponsoredTrump’s “Tax Free” Retirement StrategySince 1924 — over one hundred years — the US dollar has lost nearly 18x its value. If you're planning on re...Gold Safe Exchange | SponsoredIt’s over.We found a tiny company which provides the backbone for the entire $15.7 trillion AI industry... It's used ...Behind the Markets | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredThe most serious warning of my careerWith the 2024 election just weeks away, a new crisis is barrelling down on America… one that could cleave the ...Porter & Company | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atlas Arteria Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Atlas Arteria With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.